Paratus Sciences Hires Theresa Heah As CEO

KUALA LUMPUR, Feb 22 (Bernama) -- Paratus Sciences Corporation, a biotechnology company accelerating the discovery of novel therapeutics by leveraging the extraordinary adaptive biology of bats, has appointed Dr Theresa Heah as Chief Executive Officer (CEO) and a member of its Board of Directors.

According to a statement, Dr Heah brings over two decades of drug development and commercial experience in therapeutics and platform technologies to Paratus.

“Theresa brings a tremendous wealth of experience as a seasoned pharma and biotech executive, having spearheaded the development and commercialisation of multiple innovative therapies.

“She is well poised to guide Paratus as it continues to build its proprietary platform, advance its novel discovery portfolio, and grow its team and capabilities,” said the company’s founding CEO, chair of its Board of Directors and Polaris Partners Executive Partner, Amir Nashat.

Meanwhile, Dr Heah said Paratus’s unique scientific premise, coupled with its proprietary bioinformatics and genomics-rich platform, has the potential to accelerate its ability to identify novel targets and discover innovative medicines.

“I look forward to working with our team to progress our drug discovery efforts, with an initial focus on immunology and inflammation, and metabolism,” she said.

Dr Heah most recently served as the CEO and President of Intergalactic Therapeutics, a non-viral gene therapy platform company. Prior to Intergalactic, she was Chief Medical Officer at several companies, namely Kriya Therapeutics where she also served as President; and AsclepiX Therapeutics also as Executive Vice President of Operations.

Earlier in her career, she held leadership positions in a number of private and public companies, including Aerie Pharmaceuticals, Allergan, Bayer Healthcare, Fovea Pharmaceuticals and Sanofi.

Dr Heah trained as a physician at the University of London, United Kingdom, specialising in ophthalmology, and later earned her Executive Master of Business Administration (MBA) from the European School of Management & Technology (ESMT) in Berlin.

-- BERNAMA